BOTALYS

Belgium
Ghislenghien, Wallonia, Belgium, 7822

Company profile

BOTALYS company profile

OUR MISSION We are Botanical Explorers seeking the next frontier of plant health benefits while preserving wild biotopes. We firmly believe that medicinal plants deserve a new standard of uncompromising quality, and we are committed to explore their health potential further while respecting the planet. Hence, our two core values: Explore & Respect. OUR VISION Indoor Precision Farming offers a unique opportunity to sustainably grow potent medicinal plants. We have developed our own indoor farming approach under ultra-clean conditions. Our cultivation facilities are one of the largest vertical farms in Europe. There, by optimizing the growth environment, we ensure that our botanicals reach their full potential in terms of Health benefits, bringing full-spectrum product to the next level, and combining Wild Quality with Lab purity. OUR PRODUCT With more than 3000 years of medicinal tradition and more than 5000 scientific publications about its health benefits, Korean red ginseng (Panax ginseng CA Meyer) is, without a doubt, the most precious and revered medicinal plant in the world. At BOTALYS, we are shaping its molecular profile, making our full-spectrum ginseng root powder comparable to a 20 years old wild Korean ginseng specimen. And ginseng is just the first botanical milestone of our journey…

Business identity

Contact email
[email protected]
Phone number
+32 (0)68 33 18 08
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2011-02-18

Headquarters

Postal code
7822
Country code
BE
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
11
Total equity funding
$14.4M
Last funding
Convertible Note / $3.4M / 2025-11-21
Last equity funding
Series B / $686,815
Investors
7
Lead investors
1
Founders
2
Articles
12

Founders and investors

Founders

Paul-Evence CoppéePierre-Antoine Mariage

Lead investors

Air Liquide ALIAD

Investors

Horizon 2020S.R.I.W.Teseo CapitalThe Yield Lab EuropeVives Louvain Technology Fund